Table 1.
Baseline characteristics.
| Demographics | Controls (n=14) | Patients (n=14) |
|---|---|---|
| DPSI, 0-4 | 2.9 ± 0.3 | 3.9 ± 0.2** |
| Mean PPD, mm | 3.7 ± 0.6 | 5.0 ± 1.3** |
| Deepest PPD, mm | 4.6 ± 0.7 | 6.4 ± 1.6** |
| Age, years | 54 ± 10 | 63 ± 6* |
| Sex, % men | 57 (8) | 36 (5) |
| BMI, kg/m2 | 24.9 ± 3.5 | 28.0 ± 6.5 |
| SBP, mmHg | 130 ± 17 | 137 ± 17 |
| DBP, mmHg | 80 ± 7 | 89 ± 12 |
| Hypertension, % (n) | 43 (6) | 64 (9) |
| Alcohol consumption, 0-8 | 3.3 ± 1.7 | 2.9 ± 1.4 |
| Current smoking, % (n) | 14 (2) | 7 (1) |
| Smoking, packyears | 4.5 ± 5.7 | 15.8 ± 18.2* |
| Anti-hypertensive treatment, % (n) | 14 (2) | 29 (4) |
| Lipid lowering therapy, % (n) | 7 (1) | 29 (4) |
| Fasting glucose, mmol/L | 5.1 ± 0.4 | 5.4 ± 0.4 |
| Creatinine, mmol/L | 79 ± 12 | 75 ± 10 |
| Tchol, mmol/L | 4.96 ± 0.47 | 5.18 ± 0.76 |
| LDLc, mmol/L | †2.65 ± 0.44 | 2.90 ± 0.67 |
| HDLc, mmol/L | 1.41 ± 0.47 | 1.44 ± 0.37 |
| TG, mmol/L | 1.92 ± 1.19 | 1.90 ± 0.88 |
| nHDLc, mmol/L | †3.52 ± 0.73 | 3.76 ± 0.84 |
Demographics are reported as mean ± SD or % (number of participants) in control participants (n = 14) and participants with periodontitis (n = 14). Normally distributed data were analyzed using independent samples T-test, qi-square test was used for categorial data. Anti-hypertensive treatment includes beta-blockers, ACE-inhibitors, ARB’s and thiazide diuretics. Alcohol consumption is the sum of alcohol consumption frequency (0-4, ranging from never: 0 to >4x/week:4) and alcohol consumption quantity per occasion (0-4, ranging from 1-2 drinks:0 to >10 drinks:4) based on the Alcohol Use Disorders Identification Test questions. †Data is missing for 1 participant. * indicates P < 0.05, **P < 0.01. PPD, probing pocket depth. Bold values express differences of interest, with a p-value <0.10.